DeVilbiss 10 LPM vs Home Medix HM-KX 10 LPM

The DeVilbiss 10 LPM and the Home Medix HM-KX 10 LPM occupy opposite ends of the high-flow stationary category in the Indian market. DeVilbiss is the American industrial-duty benchmark — FDA approved, CE certified, the lightest 10 LPM unit on Indian shelves at a published 19 kg. HM-KX is the Indian feature-dense challenger — field-verified ≤ 48 dB(A), 550 VA draw (lowest in the 10 LPM class on published specs), integrated nebulization, dealer-validated one-touch SOS siren, and CDSCO documentation. The price split is wide — HM-KX at roughly ₹65,000 street in 2026 against DeVilbiss at roughly ₹1,10,000 depending on channel. This is a context-dependent call.

At a glance

• Price. HM-KX indicative retail roughly ₹65,000 in 2026 (listed MRP ₹85,000). DeVilbiss indicative retail roughly ₹1,10,000 (listed MRP ₹1,58,400). HM-KX is roughly ₹45,000 cheaper.
• Weight. DeVilbiss 19 kg vs HM-KX 25.6 kg — DeVilbiss is 6.6 kg lighter and the lightest 10 LPM unit in class.
• Flow range. HM-KX 0.5–10 L/min vs DeVilbiss 2–10 L/min.
• Oxygen purity. HM-KX 93% ± 3% (90–96%) vs DeVilbiss 87–96%.
• Sound level (published). HM-KX ≤ 48 dB(A) field-verified vs DeVilbiss 67 dB — roughly a 19 dB gap, a very large perceived-loudness difference.
• Power consumption. HM-KX 550 VA vs DeVilbiss 664 W — HM-KX ~17% lower on published specs.
• Outlet pressure. HM-KX 0.04–0.06 MPa (~5.8–8.7 psi) vs DeVilbiss 20 psi.
• Warranty. HM-KX 3 years or 10,000 hours, whichever first. DeVilbiss 2 years on the Indian channel.
• Regulatory. HM-KX ISO 9001 + ISO 13485 + CDSCO. DeVilbiss US FDA + CE.

Where the HM-KX wins

Sound floor. HM-KX’s ≤ 48 dB(A) is field-verified and sits at the floor of the Indian 10 LPM class. DeVilbiss publishes 67 dB on its Indian listing — a ~19 dB gap, which is roughly four-times the perceived loudness. For bedside overnight placement, a concentrator running at 67 dB becomes an adjacent-room-with-tubing-extension unit in most Indian households; at ≤ 48 dB the same placement is a patient-tolerance call rather than a default exile. For a chronic LTOT patient facing 16–20 hours a day of therapy, this is the single most user-facing difference.

Power draw. HM-KX at 550 VA is the lowest in the 10 LPM class on published specs; DeVilbiss at 664 W is among the highest. At ₹8/kWh tariff, 24/7 operation of the HM-KX costs roughly ₹3,200/month against roughly ₹3,800/month for the DeVilbiss — ~₹600/month spread, ~₹7,200/year. Over three years that is ~₹22,000. Stabiliser sizing also shifts: HM-KX pairs with an 825 VA servo stabiliser; DeVilbiss needs roughly 1,000 VA in the same role.

Integrated nebulization. HM-KX can deliver oxygen-entrained nebulized medication through the same circuit. DeVilbiss 10 LPM does not integrate this, so a separate compressor nebulizer stays in the home setup budget.

One-touch SOS alert. HM-KX ships with a factory-integrated high-volume audible SOS button — a local distress siren loud enough to carry to an adjacent room or floor in a typical Indian home. No mobile app, no SMS, no telecom channel; it is a hardwired siren, and the feature has been validated across 100+ dealer deployments. Genuinely useful for bedridden or voice-weak patients whose call would not otherwise carry. DeVilbiss has no equivalent.

Price. HM-KX at roughly ₹65,000 against DeVilbiss at roughly ₹1,10,000 is a ~₹45,000 saving — effectively a secondary 5 LPM unit, a year of consumables, or bridge-rental budget.

Alarms, AC tolerance, hour counter. HM-KX publishes a full alarm suite (Low Oxygen Concentration, Power Failure, High Temperature, Low/No Flow), an AC 230V ±10% (207–253 V) tolerance window, and an on-panel running-hour display. DeVilbiss publishes Loss of Power and No Flow — a narrower published alarm set, and no hour counter on the same datasheet.

Where DeVilbiss wins

FDA + CE paperwork. DeVilbiss carries US FDA approval and CE certification. HM-KX carries CDSCO, ISO 9001, and ISO 13485. For procurement processes that explicitly require FDA listing (some corporate-buyer tenders, hospital empanelments, international rental fleets), DeVilbiss clears the checkbox HM-KX does not.

Weight. 19 kg vs 25.6 kg — DeVilbiss is 6.6 kg lighter, and the lightest 10 LPM stationary unit in this comparison. Relocation across stairs or between floors becomes a one-person job at 19 kg in a way it is not at 25.6 kg.

Outlet pressure. DeVilbiss publishes 20 psi against the HM-KX’s 0.04–0.06 MPa (~5.8–8.7 psi). For long tubing runs, humidifier-bottle setups with back-pressure, and certain ventilator-bridging configurations, 20 psi sustains delivered flow more reliably at the patient end.

Industrial-duty lineage and brand recognition. DeVilbiss is the American industrial-duty benchmark, trusted by rental fleets and institutional buyers globally. Indian pulmonologists, hospital biomedical-equipment teams, and rental-fleet operators recognise the name — prescription-channel pull and institutional procurement preference both favour DeVilbiss where the decision-maker is not the end patient.

Wider FDA-aligned service channel. DeVilbiss’s global service footprint means authorised-channel parts move through an older, deeper supply pipeline than HM-KX’s domestic channel — relevant for buyers outside Home-Medix-served cities.

Indian-market considerations

• Stabiliser sizing. HM-KX at 550 VA → 825 VA servo stabiliser (1.5× rated). DeVilbiss at 664 W needs a 1,000 VA unit. Factor roughly ₹3,500–₹6,500 into either setup. For areas with frequent outages, pair with an online UPS or a pure-sine inverter — never a square-wave inverter, which damages the compressor motor.
• Electricity cost. 24/7 HM-KX at ₹8/kWh is ~₹3,200/month; DeVilbiss ~₹3,800/month — ~18–19% lower for HM-KX. Over 36 months of LTOT, operating cost narrows the upfront gap but does not close it.
• Altitude derating. Both units see a 2–4% purity drop above 2,000 m. DeVilbiss publishes 5,000 ft (~1,525 m); HM-KX does not publish an altitude rating. For Leh, Manali, Gangtok, and Shimla residents, this is a flag for both units.
• GST, CGHS, ECHS. 12% GST applies to both. Qualifying buyers can route through CGHS, ECHS, ESIC, or private-insurance home-medical-equipment reimbursement with a full GST-invoiced purchase and a standing oxygen prescription.
• Service reach. DeVilbiss’s Indian authorised channel runs through established biomedical distributors with metro-heavy coverage. HM-KX service is concentrated in South and West India with thinner reach into the North-East and hill belts. For buyers outside either footprint, get written warranty-turnaround and spare-parts commitments from the dealer before purchase.

Who should pick which

Pick the DeVilbiss 10 LPM if FDA-listed paperwork is a procurement requirement, if the unit is destined for heavy institutional duty where compressor longevity reputation carries the purchase, if the setup involves long tubing runs or high-back-pressure pairings where 20 psi outlet pressure matters, or if the 6.6 kg weight saving is load-bearing for the household layout. DeVilbiss is the right answer for rental fleets, nursing-home deployments, and institutional-procurement buyers anchored to FDA listing.

Pick the Home Medix HM-KX 10 LPM if the buyer is a home LTOT patient in a Home-Medix-served city, if overnight sound floor is a first-order concern, if the patient is also on nebulized medication and the integrated nebulizer removes the need for a second compressor, if the caregiver-presence dynamic makes the SOS siren genuinely useful, if a sub-2 L/min flow prescription is part of the picture, or if the ~₹45,000 price saving is meaningful to the budget.

Verdict

Context-dependent tie on the merits. DeVilbiss wins for FDA-paperwork, institutional-duty, long-tubing, and lightest-carry use cases. HM-KX wins for quiet home LTOT, concurrent-nebulization, caregiver-presence, and value-first use cases. Neither unit is universally better; the purchase axis decides. For heavy-institutional FDA-required buyers, DeVilbiss. For home LTOT value, HM-KX.

Before committing to any 10 LPM unit, confirm the prescription genuinely requires >5 L/min — many patients are over-specced and a 5 LPM unit covers the need at ~40% less. Consult the prescribing pulmonologist on the actual flow trajectory before the purchase.